Oxidized cholesterol in the diet is a source of oxidized lipoproteins in human serum

Journal of Lipid Research

Volumn 44, Issue 4, 2003, Pages 705-715

  Staprans, Ilona ^a   Pan, Xian Mang ^a   Rapp, Joseph H ^a   Feingold, Kenneth R ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cholestan 5 ,6 epoxy 3 ol; Chylomicron chylomicron remnants; Type III hyperlipoproteinemia

Indexed keywords

ALPHA EPOXYCHOLESTEROL; CHOLESTAN 5ALPHA,6ALPHA EPOXY 3BETA OL; CHOLESTEROL; CHOLESTEROL DERIVATIVE; CHOLESTEROL ESTER TRANSFER PROTEIN; CHYLOMICRON; COPPER; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL DIET; CHOLESTEROL TRANSPORT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERLIPOPROTEINEMIA TYPE 3; IN VITRO STUDY; INCUBATION TIME; LIPID ABSORPTION; LIPID OXIDATION; LIPOPROTEIN BLOOD LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SERUM; TEST MEAL;

CARRIER PROTEINS; CASE-CONTROL STUDIES; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEINS; CHYLOMICRON REMNANTS; CHYLOMICRONS; DIET; GLYCOPROTEINS; HUMANS; HYPERLIPOPROTEINEMIA TYPE III; LIPOPROTEINS; OXIDATION-REDUCTION; TIME FACTORS;

EID: 0142105845     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M200266-JLR200     Document Type: Article

References (55)

1. Steinberg, D. 1997. Oxidative modification of LDL and atherogenesis. Circulation. 95: 1062-1071.
2. Chisolm, G. M., and M. S. Penn. 1996. Oxidized lipoproteins and atherosclerosis. In Atherosclerosis and Coronary Heart Disease. V. Fuster, R. Ross, and E.J. Topol, editors. Raven Press, NY. 129-149.
3. Palinski, W., M. E. Rosenfeld, S. Yla-Herttuala, G. C. Gurtner, S. S. Socher, S. W. Butler, S. Parthasarathy, T. E. Carew, D. Steinberg, and J. L. Witztum. 1989. Low density lipoprotein undergoes oxidative modification in vivo. Proc. Natl. Acad. Sci. USA. 86: 1372-1376.
4. Yla-Herttuala, S., W. Palinski, M. E. Rosenfeld, S. Parthasarathy, T. E. Carew, S. Butler, J. L. Witztum, and D. Steinberg. 1989. Evidence for the presence of oxidatively modified LDL in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 84: 1086-1095.
5. Carew, T. E., D. C. Schwenke, and D. Steinberg. 1987. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit LDL degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. Proc. Natl. Acad. Sci. USA. 84: 7725-7729.
6. Kita, T., Y. Nagano, M. Yokode, K. Ishii, N. Kume, A. Ooshima, H. Yoshida, and C. Kawai. 1987. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proc. Natl. Acad. Sci. USA. 84: 5928-5931.
7. Parker, A. R., T. Sabrah, M. Cap, and B. T. Gill. 1995. Relation of vascular oxidative stress, α-tocopherol, and hypercholesterolemia to early atherosclerosis in hamsters. Arterioscler. Thromb. Vasc. Biol. 15: 349-358.
8. Addis, P. B., and C. A. Hassel. 1992. Safety issues with antioxidants in foods. In Food Safety Assessment. J. W. Finley, S. Robinson, and D. J. Armstrong, editors. American Chemists Society, Washington, DC. 346-376.
9. Yagi, K., K. Kiuchi, Y. Saito, A. Miike, N. Kayahara, T. Tatano, and N. Ohishi. 1986. Use of a new methylene blue derivative for determination of lipid peroxides in foods. Biochem. Int. 12: 367-371.
10. Addis, P. B., P. W. Park, F. Guardiola, and R. Codony. 1996. Analysis and health effects of cholesterol oxides. In Food Lipids and Health. R. E. McDonald and D. B. Min, editors. Marcel Dekker, Inc., NY. 199-240.
11. Van de Bovenkamp, P., T. G. Kosmeijer-Schuil, and M. B. Katan. 1988. Quantification of oxysterols in Dutch foods: egg products and mixes diets. Lipids. 23: 1079-1085.
12. Addis, P. B., and P. W. Park. Cholesterol oxide content in food. 1992. In Biological effects of cholesterol oxides. S. K. Peng and R. J. Morin, editors. CRC press, Boca Raton, FL. 71-88.
13. Angulo, A. J., J. M. Romera, M. Ramirez, and A. Gil. 1997. Determination of cholesterol oxides in dairy products. Effects of storage conditions. J. Agric. Food Chem. 45: 4318-4323.
14. Staprans, I., J. H. Rapp, X-M. Pan, and K. R. Feingold. 1993. The effect of oxidized lipid in the diet on serum lipoprotein peroxides in control and diabetic rats. J. Clin. Invest. 92: 638-643.
15. Staprans, I., X-M. Pan, M. Miller, and J. H. Rapp. 1993. Effect of dietary lipid peroxides on metabolism of serum chylomicrons in rats. Am. J. Physiol. 264: G561-G568.
16. Staprans, I., J. H. Rapp, X-M Pan, and K. R. Feingold. 1996. Oxidized lipids in the diet are incorporated by the liver into VLDL in rats. J. Lipid Res. 37: 420-430.
17. Staprans, I., J. H. Rapp, X-M. Pan, D. A. Hardman, and K. R. Feingold. 1996. Oxidized lipids in the diet accelerate lipid deposition in the arteries of cholesterol-fed rabbits. Arterioscler. Thromb. Vasc. Biol. 16: 533-538.
18. Bascoul, J., N. Domerque, J. Mourot, G. Derby, and A. Crastes de Paulet. 1986. Intestinal absorption and fecal excretion of 5,6α-epoxy-5α -cholesta-3β-ol by male Wistar rat. Lipids. 21: 744-747.
19. Osada, K., E. Sasaki, and M. Sugano. 1994. Lymphatic absorption of oxidized cholesterol in rats. Lipids. 29: 555-559.
20. Peng, S. K., G. A. Phillips, G-Z., Xia, and R. J. Morin. 1987. Transport of cholesterol autoxidation products in rabbit lipoproteins. Atherosclerosis. 64: 1-6
21. Vine, D. F., J. C. L. Mamo, L. J. Beilin, T. Mori, and K. D. Croft. 1998. Dietary oxysterols are incorporated in plasma triglyceride-rich lipoproteins, increase their susceptibility to oxidation and increase aortic cholesterol concentration in rabbits. J. Lipid Res. 39: 1995-2004.
22. Staprans, I., X-M. Pan, J. H. Rapp, and K. R. Feingold. 1998. Oxidized cholesterol in the diet accelerates the development of aortic atherosclerosis in cholesterol-fed rabbits. Arterioscler. Thromb. Vasc. Biol. 18: 977-983.
23. Staprans, I., X-M. Pan, J. H. Rapp, C. Grunfeld, and K. R. Feingold. 2000. Oxidized cholesterol in the diet accelerate the development of atherosclerosis in LDL-receptor- and apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 20: 708-714.
24. Staprans, I., J. H. Rapp, X-M. Pan, K. Y. Kim, and K. R. Feingold. 1994. Oxidized lipids in the diet are a source of oxidized lipid in chylomicrons of human serum. Arterioscler. Thromb. 14: 1900-1905.
25. Staprans, I., D. A. Hardman, X-M. Pan, and K. R. Feingold. 1999. Effect of oxidized lipids in the diet on oxidized lipid levels in serum chylomicrons of diabetic patients. Diabetes Care. 22: 300-306.
26. Mahley, R. W. 1987. Alterations in plasma lipoproteins induced by cholesterol feeding in animals including man. In Disturbances in Lipid and Lipoprotein Metabolism. J. M. Dietschy, A. M. Gotto and J. A. Ontko, editors. American Physiological Society, Bethesda, MD. 181-197.
27. Dzeletovic, S., O. Breuer, E. Lund, and U. Diczfalusy. 1995. Determination of cholesterol oxidation products in human plasma by isotope dilution-mass spectrometry. Anal. Biochem. 225: 73-80.
28. Sevanian, A., H. N. Hodis, J. Hwang, L. L. Mcleod, and H. Peterson. 1995. Characterization of endothelial cell injury by cholesterol oxidation products found in oxidized LDL. J. Lipid Res. 36: 1971-1986.
29. Murakami, H., N. Tamasawa, J. Matsui, M. Yasujima, and T. Suda. 2000. Plasma oxysterols and tocopherol in patients with diabetes mellitus and hyperlipidemia. Lipids. 35: 333-338.
30. Vaya, J., M. Aviram, S. Mahmood, T. Hayek, and E. Grenadier. 2000. Selective distribution of oxysterols in atherosclerotic lesions and in human plasma lipoproteins. Free Rad. Res. 34: 485-497.
31. Breuer, O., S. Dzeletovic, E. Lund, and U. Diczfalusy. 1996. The oxysterols cholest-5ene-3β,4α-diol, cholest-5-ene-3β,4β -diol and cholestane-3β,5α,6α-triol are formed during the in vitro oxidation of low density lipoprotein, and are present in human atherosclerotic plaques. Biochim. Biophys. Acta. 1302: 145-152.
32. Kudo, K., G. T. Emmons, E. W. Casserly, D. P. Vis, L. C. Smith, and J. St Pyrek, and G.J. Schroepfer. 1989. Inhibitors of sterol synthesis. Chromatography of acetate derivatives of oxygenated sterols. J. Lipid Res. 30: 1097-1111.
33. Schneeman, B. O., L. Kotite, K. M. Todd, and R.J. Havel. 1993. Relationship between the response of triglyceride-rich lipoproteins in blood plasma containing apolipoproteins B-48 and B-100 to a fat-containing meal in normolipemic humans. Proc. Natl. Acad. Sci. USA. 90: 2069-2073.
34. Campos, E., L. Kotite, P. Blanche, M. Yasushi, P. H. Frost, U. Masharani, R. M. Krauss, and R. J. Havel. 2002. Properties of triglyceride-rich and cholesterol-rich lipoproteins in the remnant-like particle fraction of human blood plasma. J. Lipid. Res. 43: 365-374.
35. Havel, R. J., H. Eder, and J. Bragdon. 1955. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34: 1345-1353.
36. Guerin, M., P. J. Dolphin, and M. J. Chapman. 1994. A new in vitro method for simultaneous evaluation of cholesteryl ester exchange and mass transfer between HDL and apoB-containing lipoprotein subspecies. Arterioscl. Thromb. 14: 199-206.
37. Esterbauer, H., G. Striegl, H. Puhl, and M. Rotheneder. 1989. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Rad. Res. Comm. 6: 67-75.
38. Hughes, H., B. Mathews, M. L. Lenz, and J. R. Guyton. 1994. Cytotoxicity of oxidized LDL to porcine aortic smooth muscle cells is associated with oxysterols 7-ketocholesterol and 7-hydroxycholesterol. Arterioscler. Thromb. 14: 1177-1185.
39. Lin, C. Y., and D. W. Morel. 1996. Esterification of oxysterols in human serum: effects on distribution and cellular uptake. J. Lipid Res. 37: 168-178.
40. Fruebis, J., D. Steinberg, H. A. Dresel, and T. E. Carew. 1994. A comparison of the antiatherogenic effects of probucol and low density lipoprotein receptor-deficient rabbits. J. Clin. Invest. 94: 392-398.
41. Tall, A. R. 1993. Plasma cholesteryl ester transfer protein. J. Lipid Res. 34: 1255-1274.
42. Serdyuk, A. P., and R. E. Morton. 1999. Lipid transfer inhibitor protein defines the participation of lipoproteins in lipid transfer reactions. CETP has no preference for cholesteryl esters in HDL versus LDL. Arterioscler. Thromb. Vasc. Biol. 19: 718-726.
43. Aw, T. Y., M. W. Williams, and L. Gray. 1992. Absorption and lymphatic transport of peroxidized lipids by rat small intestine in vivo: role of mucosal GSH. Am. J. Physiol. 262: G99-G106.
44. Findlay, G. M., H. H. Draper, and J. G. Bergan. 1970. Metabolism of 1-14C-methyl linoleate hydroperoxide in the rabbit. Lipids. 5: 970-975.
45. Brown, J. A., and W. Jessup. 1999. Oxysterols and atherosclerosis. Atherosclerosis. 142: 1-28.
46. Hayden, J. M., L. Brachova, K. Higgins, L. Obermiller, A. Sevanian, S. Khandrika, and P. D. Reaven. 2002. Induction of monocyte differentiation and foam cell formation in vitro by 7-ketocholesterol. J. Lipid Res. 43: 26-35.
47. Rong, J. X., S. Rangaswamy, L. Shen, R. Dave, J. H. Chang, H. Peterson, H. N. Hodis, G. M. Chisolm, and A. Sevanian. 1998. Arterial injury by cholesterol oxidation products causes endothelial dysfunction and arterial wall cholesterol accumulation. Arteriosler. Thromb. Vasc. Biol. 18: 1885-1894.
48. Jacobson, M. S., M. G. Price, A. E. Shamoo, and F. P. Heald. 1985. Atherogenesis in White Carneau pigeons: effect of low-level cholestanetriol feeding. Atherosclerosis. 57: 209-217.
49. Peng, S. K., C. B. Taylor, E. H. Mosbach, W. Y. Huang, J. Hill, and B. Mikkelson. 1982. Distribution of 25-hydroxycholesterol in plasma lipoproteins and its role in atherogenesis. A study in squirrel monkeys. Atherosclerosis. 41: 395-402.
50. Zieden, B., A. Kaminskas, M. Kristenson, Z. Kucinkiene, B. Vessby, A. G. Olsson, and U. Diczfalusy. 1999. Increased plasma 7β-hydroxy-cholesterol concentrations in a population with high risk of cardiovascular disease. Arterioscler. Thromb. Vasc. Biol. 19: 967-971.
51. Yasunobu, Y., K. Hayashi, T. Shingu, T. Yamagata, G. Kajiyama, and M. Kambe. 2001. Coronary atherosclerosis and oxidative stress as reflected by autoantibodies against oxidized low-density lipoprotein and oxysterols. Atherosclerosis. 155: 445-453.
52. Tribble, D. L., L. G. Holl, P. D. Wood, and R. M. Krauss. 1992. Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size. Atherosclerosis. 93: 189-199.
53. de Graaf, J., H. I. M. Hak-Iemers, M. P. C. Hectors, P. N. M. Demacker, J. C. M. Hendriks, and A. F. H. Stalenhoef. 1991. Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. Arterioscler. Thromb. Vasc. Biol. 11: 298-306.
54. Parthasarathy, S., J. C. Khoo, E. Miller, J. Barnett, J. L. Witztum, and D. Steinberg. 1990. Low density lipoprotein rich in oleic acid is protected against oxidative modification: implication for dietary prevention of atherosclerosis. Proc. Natl. Acad. Sci. USA. 87: 3894-3898.
55. Thomas, M. J., T. Thornburg, J. Manning, K. Hooper, and L. Rudel. 1994. Fatty acid composition of low-density lipoprotein influences its susceptibility to autoxidation. Biochemistry. 33: 1828-1834.